Cronos Group Inc. Common Share

Day range

$3.30 – $3.43

Open

$3.43

Prev close

$3.45

Volume

526.57K

Market cap

$1.27B

Shares out

368.54M

P/E

18.16

P/S

4.94

P/B

1.19

P/FCF

25.51

ROE

6.6%

ROA

5.9%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 22, 2026

• Deal agreementsOct 15, 2026

  On October 15, 2026, Cronos Group Inc. ... and its wholly owned subsidiary, CGM B.V. ... entered into an Addendum ... to the Share Sale and Purchase Agreement ... with "Ring" International Holding AG and Landewyck Tobacco S.A. for the acquisition of CanAdelaar B.V.

• Deal agreementsSep 11, 2026

  On September 8, 2026, Cronos Group Inc., its indirect wholly owned subsidiary CGM B.V., Ring International Holding AG, and Landewyck Tobacco S.A. entered into an amendment to the Share Sale and Purchase Agreement relating to the acquisition by the Purchaser of all of the issued and outstanding shares of CanAdelaar B.V., a private company and one of ten licensed cannabis growers in the Dutch Controlled Cannabis Supply Chain Experiment.

• Shareholder meetingsJun 22, 2026

  Cronos Group Inc. (the "Company") held its 2026 Annual Meeting of Shareholders on June 18, 2026 (the "Meeting"). The proposals voted upon at the Meeting and the final results of the shareholder vote on each proposal are set forth below.

• Shareholder returnsMay 11, 2026

  On May 11, 2026, the Company announced that its Board of Directors authorized a share repurchase program of up to $50 million, which is intended to succeed the Company's existing share repurchase program upon its scheduled expiration on May 13, 2026. The share repurchase program is expected to commence on May 14, 2026 and terminate on May 13, 2027, unless earlier terminated.

• Deal agreementsDec 9, 2025

  The consummation of the Transaction is subject to certain customary conditions to closing, including (i) written unconditional confirmation in form and substance satisfactory to Dutch BidCo from the Dutch Minister of Health, Welfare and Sport (the "Minister") that the Transaction does not constitute grounds for revocation of CanAdelaar's license under the Experiment and that the Minister will not revoke or seek to remove CanAdelaar's license in the context of the Transaction, (ii) written confirmation from the Minister that a Bibob screening (background check) by the Minister and the Dutch National Probity Screening Authority has been completed in the context of the Transaction without conditions having been imposed, (iii) the absence of a material adverse effect on CanAdelaar, (iv) subject to certain materiality qualifiers, the truth and accuracy of the Sellers' warranties made in the Purchase Agreement and (v) no governmental authority having issued an order relating to the Odor Issue (as defined in the Purchase Agreement).

• TLRYTilray Brands, Inc. Common Stock-4.03%
• SNDLSundial Growers Inc. Common Shares+0.00%
• SNDLSundial Growers Inc. Common Shares+0.00%
• TLRYTilray Brands, Inc. Common Stock-4.03%
• CGCCanopy Growth Corporation Common Shares+0.01%
• OGIOrganigram Global Inc. Common Shares-1.27%
• ACBAurora Cannabis Inc. Common Shares-1.89%

Days to cover

3.8

Short interest

3.37M

Avg volume

896.12K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
  positiveGlobeNewswire Inc.· Oct 15, 2026
• CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
  neutralZacks Investment Research· Oct 9, 2026
• 2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026
  positiveThe Motley Fool· Sep 22, 2026
• Why Trump Media Stock Just Sank 9.4%
  negativeThe Motley Fool· Aug 10, 2026
• Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
  negativeThe Motley Fool· May 22, 2026